PATTERN OF ANTIBIOTIC USE IN DERMATOLOGY CLINIC: AN AWARE BASED CROSS-SECTIONAL STUDY IN A TERTIARY CARE HOSPITAL IN SOUTH INDIA

Main Article Content

Dr. Devika Hari
Dr. Devika Jayachandran
Dr. Devika Sajeevan
Dr. Deyon Benny
Dr. Divya Rani
Dr. Chintha Sujatha

Keywords

AWaRe, antibiotic, antimicrobial resistance, dermatology, outpatient, tertiary care hospital, India

Abstract

Antimicrobial resistance (AMR) is a steadily worsening and silent pandemic, posing a great challenge to public health for effective disease control. The Access, Watch, Reserve (AWaRe) classification of antibiotics was launched by World Health Organisation (WHO) as a part of Global Action Plan on AMR to optimise antibiotic use. Antibiotics should be ideally prescribed from Access group to curb resistance. Monitoring antibiotic prescribing data will help to develop evidence-based guidelines to promote rational antimicrobial therapy. This study assessed the pattern of antibiotic use in dermatology clinic in a tertiary care hospital using WHO AWaRe classification.


Methods


We conducted a cross-sectional study on 112 outpatients who received antibiotics in dermatology clinic using a consecutive sampling method. After obtaining informed consent, prescriptions written by dermatologist were observed and data was entered in the predesigned semi-structured case proforma. Data analysis was done using SPSS IBM 27 software.


Results


A total of 180 antibiotics were prescribed for 12 different dermatological disorders. As per WHO AWaRe tool, 73(69.5%) of antibiotics belonged to Access group, followed by Watch 31(29.5%) and Reserve group 1(1%). Doxycycline 33(29.5%) was the most commonly prescribed antibiotic followed by amoxicillin-clavulanic acid 28(25.0%).


Conclusion


Our study findings align with the target set by WHO that by the year 2023, at least 60% of overall antibiotic use should be from Access group to combat rising resistance and preserve their efficacy. This study will help in generating guidelines for rational antibiotic prescribing policy in hospitals and ultimately benefit patients to receive optimal drug therapy.

Abstract 11 | Pdf Downloads 1

References

[1] O'Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. London: Review on Antimicrobial Resistance; 2014. Available from: https://amr-review.org/sites/default/files/AMR%20Review%20Paper%20-%20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf;
[2] World Health Organization. Global action plan on antimicrobial resistance. Available from: https://www.who.int/publications/i/item/9789241509763.
[3] World Health Organization. In the face of slow progress, WHO offers a new tool and sets a target to accelerate action against antimicrobial resistance. Available from: https://www.who.int/news/item/18-06-2019-in-the-face-of-slow-progress-who-offers-a-new-tool-and-sets-a-target-to-accelerate-action-against-antimicrobial-resistance.
[4] Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol 2017;153(5):406-12.
[5] Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386(9995):743–800.
[6] Sastry AS, Bhat S. Essentials of Medical Microbiology. 3rd edn. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd 2022:504-5.
[7] Suda KJ, Hicks LA, Roberts RM, Hunkler RJ, Danziger LH. A national evaluation of antibiotic expenditures by healthcare setting in the United States, 2009. Journal of Antimicrobial Chemotherapy 2013;68(3):715–8.
[8] Centers for Disease Control and Prevention. Outpatient antibiotic prescriptions - United States, 2022. Available from: https://archive.cdc.gov/#/details?url=https://www.cdc.gov/antibiotic-use/data/report-2022.html
[9] Zanichelli V, Sharland M, Cappello B, Moja L, Getahun H, Pessoa-Silva C, et al. The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance. Bull World Health Organ 2023;101(4):290–6.
[10] Bahelah SO, Abdo GM. Prescription patterns of antibiotics in five dermatologic outpatient clinics: a cross sectional study from Yemen. JPPCM 2016;2(3):65–9.
[11] Divyashanthi CM, Nandhini A, Kumar SA. Study on drug utilization pattern of antibiotics among dermatology in-patients of a tertiary care teaching hospital, Karaikal, Puducherry. Int J Basic Clin Pharmacol 2014;3(6):1072-7.
[12] Sewell MJ, Burkhart CN, Morrell DS. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 13th ed. New York: McGraw-Hill Education 2017.
[13] Valia D, Ingelbeen B, Kaboré B, Karama I, Peeters M, Lompo P, et al. Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso. Antimicrob Resist Infect Control 2022;11(1):59.
[14] Negi G, Kb A, Panda PK. Ground level utility of Access, Watch, Reserve classification: Insights from a tertiary care center in North India. World J Exp Med 2023;13(5):123-33.
[15] Mudenda S, Chomba M, Chabalenge B, Hikaambo CN, Banda M, Daka V, et al. Antibiotic prescribing patterns in adult patients according to the who aware classification: a multi-facility cross-sectional study in primary healthcare hospitals in Lusaka, Zambia. Pharmacology & Pharmacy 2022;13(10):379–92.
[16] Kiggundu R, Wittenauer R, Waswa JP, Nakambale HN, Kitutu FE, Murungi M, et al. Point prevalence survey of antibiotic use across 13 hospitals in Uganda. Antibiotics (Basel). 2022;11(2):199.
[17] Mugada V, Mahato V, Andhavaram D, Vajhala SM. Evaluation of prescribing patterns of antibiotics using selected indicators for antimicrobial use in hospitals and the Access, Watch, Reserve (AWaRe) classification by the World Health Organization. Turk J Pharm Sci 2021;18(3):282–8.
[18] Koya SF, Ganesh S, Selvaraj S, Wirtz VJ, Galea S, Rockers PC. Consumption of systemic antibiotics in India in 2019. Lancet Reg Health Southeast Asia 2022;4:100025.
[19] Ekuma A, Onukak A, Udoette S, Versporten A, Pauwels I, Oduyebo O, et al. AWaRe classification of antibiotics prescribed within 2018-2021 for hospitalized medical and surgical patients in Uyo, Nigeria. Pan Afr Med J 2023;46:80.
[20] Peddireddy M, Mahin J, Uppu A, Padi SSV. Hospital antibiotic prescribing pattern in general surgery specialty: analysis based on the WHO Access, Watch and Reserve (AWaRe) Classification. J Pharm Res Int 2021;7–19.
[21] Pauwels I, Versporten A, Drapier N, Vlieghe E, Goossens H, Global-PPS network. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries. J Antimicrob Chemother 2021;76(6):1614–24.
[22] Yin J, Li H, Sun Q. Analysis of antibiotic consumption by AWaRe classification in Shandong Province, China, 2012-2019: a panel data analysis. Front Pharmacol 2021;12:790817.
[23] Pulcini C, Beovic B, Béraud G, Carlet J, Cars O, Howard P, et al. Ensuring universal access to old antibiotics: a critical but neglected priority. Clin Microbiol Infect 2017;23(9):590–2.
[24] Rahbi FA, Salmi IA, Khamis F, Balushi ZA, Pandak N, Petersen E, et al. Physicians’ attitudes, knowledge, and practices regarding antibiotic prescriptions. J Glob Antimicrob Resist 2023;32:58–65.
[25] Hassan H, Jyothi R, Sreenadh H, Manjusree S, Reghukumar A. AWaRe-based culture reporting format: a novel tool for antimicrobial stewardship [Letter]. GMS Infect Dis 2023;11:Doc04.
[26] Hammerum AM, Heuer OE, Emborg HD, Bagger-Skjøt L, Jensen VF, Rogues AM, et al. Danish integrated antimicrobial resistance monitoring and research program. Emerg Infect Dis 2007;13(11):1633–9.